Smoking and vaping patterns during pregnancy and the postpartum: a longitudinal UK cohort survey by Bowker, Katharine et al.
Smoking and vaping patterns during pregnancy and the postpartum: a
longitudinal UK cohort survey
Authors: Katharine Bowker a, Sarah Lewis b, Michael Ussher c , Felix Naughton d, Lucy
Phillips a Tim Coleman a, Sophie Orton a, Hayden McRobbie e, Linda Bauld f, Sue Cooper a
Affiliations and addresses:
a Division of Primary Care Research and UK Centre for Tobacco and Alcohol Studies,






b Division of Epidemiology and Public Health and UK Centre for Tobacco and Alcohol
Studies, University of Nottingham, Clinical Sciences Building 2, Nottingham City Hospital
Hucknall Road, Nottingham NG5 1PB UK.
Sarah Lewis: sarah.lewis@nottingham.ac.uk
c Population Health Research Institute, St George's, University of London, London SW17
0RE UK and Institute for Social Marketing and Health, University of Stirling, Stirling, FK9
4LA UK.
Michael Ussher: mussher@sgul.ac.uk
d University of East Anglia, Faculty of medicine and health sciences. Edith Cavell Building,
Norwich NR4 7TJ UK.
Felix Naughton: f.naughton@uea.ac.uk
e National Drug and Alcohol Research Centre, University of New South Wales, Sydney,
NSW 2031 Australia.
Hayden McRobbie: h.mcrobbie@unsw.edu.au











© 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
http://creativecommons.org/licenses/by-nc-nd/4.0/
Smoking and vaping patterns during pregnancy and the postpartum: a
longitudinal UK cohort survey
Abstract:
Introduction:
There is limited information about longitudinal patterns of vaping during pregnancy and
the postpartum. We describe the prevalence, frequency, and reasons for vaping
throughout pregnancy and postpartum. We also describe temporal patterns in pregnant
women’s vaping.
Methods:
A longitudinal cohort study across England and Scotland, with questionnaires in early
pregnancy (8-24 weeks gestation), late pregnancy (34-38 weeks) and 3 months
postpartum. A total of 750 women, aged 16 years or over, who were either current
smokers, vapers or had smoked in the 3 months before pregnancy, were recruited
between June and November 2017.
Results:
Vaping prevalence was 15.9% (n=119/750) in early pregnancy: 12.4% (n=93/750)
were dual users and 3.5% (n=26/750) exclusive vapers. Late pregnancy vaping
prevalence was 17.8% (n=68/383): 12.5% (n=48/383) were dual users and 5.2%
(n=20/383) exclusive vapers. Postpartum vaping prevalence was 23.1% (n=95/411):
14.6% (n=60/411) were dual users and 8.5% (n=35/411) exclusive vapers. The most
frequently reported reason to vape among all vapers was to quit smoking. A total of 316
women completed all three surveys: 2.6% (n=8/316) were exclusive vapers in early
pregnancy with most remaining exclusive vapers postpartum (n=6/8, 75%). Of the
11.5% (n=35/316) dual users in early pregnancy, 31.4% (n=11/35) were exclusive
smokers by the postpartum.
Conclusion:
Vaping prevalence was between 15.9% and 23.1% during pregnancy and the
postpartum period, and the majority were dual users. Vaping habits of exclusive vapers
remains stable throughout pregnancy and the postpartum. However, the vaping habits of
dual users varies, with a third exclusively smoking in the postpartum.
1. Background
Smoking in pregnancy has adverse health consequences for the woman and baby
(Clifford, Lang, & Chen, 2012; Cnattingius, 2004; Delpisheh et al., 2007; Gluckman,
Hanson, Cooper, & Thornburg, 2008); efforts to eliminate smoking is a public health
priority. In England, 10.4% of women self-report smoking at delivery (NHS Digital,
2019) and rates are higher among younger and more deprived women (Health and
Social Care Information Centre., 2015; McAndrew F, 2012). Up to half of women report
quitting smoking either just before or around the time of finding out they are pregnant
(Orton et al., 2014; Pickett, Wakschlag, Dai, & Leventhal, 2003); however, up to 60% of
these may relapse in the postpartum(Colman & Joyce, 2003; Cooper et al., 2017; Jones,
Lewis, Parrott, Wormall, & Coleman, 2016). Exposure to second-hand smoke from
postpartum smoking will increase the infant’s risk of sudden infant death, respiratory
and ear infections, and asthma (Pugmire, Sweeting, & Moore, 2017). In addition,
children of women who smoke cigarettes are more likely to initiate smoking themselves
(Leonardi-Bee, Jere, & Britton, 2011).
Electronic cigarette (e-cigarette/vaping) prevalence in England in 2019 was between 5-
7% for non-pregnant adults (Ann McNeill, Brose, Calder, Bauld, & Robson, 2020). Vaping
appears to be an effective aid to assist non-pregnant smokers to quit smoking (Hajek et
al., 2019; Hartmann-Boyce et al., 2020). Although not risk free, e-cigarettes, unlike
cigarettes, do not release products of combustion (A McNeill et al., 2015). Compared to
smoking, vaping exposes non-pregnant adults to lower levels of carcinogens and toxins
(Caponnetto, Maglia, Prosperini, Busa, & Polosa, 2018; Shahab et al., 2017). Vapers who
quit smoking (exclusive vapers) have lower toxicant exposure compared to dual users
(those who smoke and vape) (Goniewicz et al., 2018). Exposure to second-hand e-
cigarette vapour may also pose less risk than exposure to second-hand cigarette smoke
(Hess, Lachireddy, & Capon, 2016). The Royal College of Physicians concluded vaping is
unlikely to exceed 5% of the harm from smoking (Royal College of Physicians, 2016).
There are limited data on the safety of vaping during pregnancy on the woman or baby
(Cardenas et al., 2019; Froggatt, Covey, & Reissland, 2020; Gillen & Saltzman, 2014;
McDonnell, Dicker, & Regan, 2020). However, it is unlikely that findings regarding
vaping safety among non-pregnant populations would be different from pregnant
women. There is currently no evidence about the effectiveness of vaping for helping
women to stop smoking during pregnancy. Current advice for clinicians caring for
pregnant women in the UK supports vaping in order to avoid smoking (Smoking in
Pregnancy Challenge Group, 2019).
Cross sectional data on vaping during pregnancy show that prevalence is between 0.6
and 15% (K. Bowker et al., 2020; Kapaya et al., 2019; Kurti et al., 2017; Liu et al.,
2019; Mark, Farquhar, Chisolm, Coleman-Cowger, & Terplan, 2015; Obisesan et al.,
2020; Rollins et al., 2020), and that most pregnant vapers also smoke (dual use) (K.
Bowker et al., 2020; Kapaya et al., 2019; Liu et al., 2019). Such variation in prevalence
figures may be influenced by different methods of data collection, recall periods, whether
women were asked about use before or at differing timepoints during pregnancy, and
variation between countries. There is limited understanding about longitudinal patterns
of vaping throughout pregnancy. If e-cigarettes are shown to be less harmful in
pregnancy than smoking, they could be a useful tool to help women who cannot quit
smoking completely using traditional methods. Finding out why and when pregnant
women vape and how this relates to smoking status would help us to understand the
context around vaping during pregnancy.
In this longitudinal cohort study, we describe the prevalence, frequency and reasons for
vaping throughout pregnancy and the postpartum. We also describe temporal patterns in
individuals’ smoking and vaping during pregnancy and postpartum. We describe whether
exposure remains stable or varies and how this relates to smoking status. Understanding
why women are vaping could help us understand women’s perceptions about the role of




A longitudinal cohort study was undertaken; eligible women were 16 years old or over
(no upper age limit), 8-24 weeks pregnant and either recent ex-smokers (smoked during
the 3 months immediately prior to finding out they were pregnant), current smokers
(every day or occasionally) and/or vapers (every day or occasionally). Surveys were
conducted in early pregnancy (8-24 weeks gestation) (baseline), late pregnancy (34-38
weeks gestation) and postpartum (3 months postpartum). Women who were unable to
read or understand the questionnaires in English or were enrolled in other smoking
cessation studies were excluded. A detailed description of the methods and
characteristics of the participants recruited is published elsewhere (K. Bowker et al.,
2020). Ethical approval was given by the South West Frenchay Research Ethics
Committee. We used “Strengthening the Reporting of Observational Studies in
Epidemiology” (STROBE) (von Elm et al., 2007) and “Transparent Reporting of
Evaluations with Nonrandomized Designs” (TREND) guidance (Des Jarlais, Lyles, Crepaz,
& Group, 2004) to aid the reporting of this study.
2.2 Study setting and regimen.
Women were recruited between June and November 2017 while attending National
Health Service (NHS) hospital antenatal clinics at a range of locations in England and
Scotland. Posters were visible in the antenatal clinics and research midwives/nurses
promoted the study by handing a questionnaire to women attending clinics. Women
completed a screening survey asking about their vaping and smoking status; those
eligible and willing then completed a full baseline survey at the same time point (consent
was implied through their completion of the questionnaire). They were then asked to
give consent to join the longitudinal cohort and be sent follow-up surveys by post or
email web-link. Written consent for longitudinal follow-up was taken face-to-face after
completing the baseline (early pregnancy) survey; however, if women required more
time, they were followed up by telephone, and verbal consent was taken. At each follow-
up, participants were sent a prompt by Short Message Service (SMS) texts to enhance
response rates, plus one reminder by post, text and/or email. If women failed to respond
they were called to complete questions by telephone. Women were offered a £10 high
street shopping voucher for completing each survey.
2.3 Description of the surveys
The early pregnancy survey included questions on age, gestation, educational
attainment, age left education, ethnicity, previous pregnancies and whether pregnancy
was planned. All three surveys contained a section about the participant’s experience of
using e-cigarettes, smoking behaviour and beliefs. Responses included yes/no answers,
Likert scales and multiple-choice options. The two follow-up surveys asked questions
about infant feeding methods and the postpartum survey asked about birthweight.
All three surveys asked current vapers about their main reason for vaping, offering eight
options. Due to low use of some of the response options, we report the top three
responses: to quit smoking, to cut down smoking, to avoid returning to smoking. This
latter option could imply women perceived themselves as established ex-smokers or may
have been ex-smokers when they started vaping. Our ‘other’ category amalgamates the
remaining responses: curiosity, enjoyment, to use when I am not allowed to smoke,
don’t know and other (unknown). Women in the postpartum were also given the option
‘to use around my baby’.
Cigarette dependence was assessed using the Heaviness of Smoking Index (HSI)
(Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991; Heatherton, Kozlowski, Frecker,
Rickert, & Robinson, 1989; Riaz et al., 2016) (time to first smoking in the morning and
number of cigarettes per day). Cigarettes smoked per day (CPD) were categorised as
either “0-10” or “≥11” to distinguish between heavy and light smokers (Husten, 2009); 
we included zero as some women smoked occasionally but not every day.
The surveys are available online as supplementary information.
2.4 Measurements
2.4.1 Smoking and vaping status at baseline
In early pregnancy, vaping status was determined on responses to the following
statement: ‘what best describes your use of e-cigarettes right now?’. Participants could
select one of the following: 1) I have never heard of e-cigarettes and have never tried
them; 2) I have heard of e-cigarettes but have never tried them; 3) I have tried e-
cigarettes, but do not use them now; 4) I have tried e-cigarettes and still use them, but
not every day; 5) I have tried e-cigarettes and still use them every day.
Smoking status was based on responses to the following statement: ‘what best describes
your smoking right now?’. Participants could select one of the following: 1) I have never
smoked; 2) I completely stopped smoking more than 3 months before finding out I was
pregnant; 3) I completely stopped smoking at some time in the 3 months before finding
out I was pregnant; 4) I completely stopped smoking after I found out I was pregnant;
5)I smoke occasionally, but not every day now I am pregnant; 6) I smoke every day,
but have cut down during my pregnancy; 7) I smoke every day, about the same as
before my pregnancy; 8) I smoke every day, and tend to smoke more than before my
pregnancy.
Ex-smokers were those who reported they were not smoking currently but had done so
during the 3 months before finding out they were pregnant. Women who reported vaping
daily or occasionally (vape, but not every day) were defined as ‘vapers’. Women who
reported that they smoked either daily or occasionally and did not vape (in any
capacity), were defined as a ‘smoker’. Smokers who reported that they also vaped (in
any capacity) were defined as ‘dual users’. Women who reported that they did not
smoke but vaped (in any capacity) were defined as ‘exclusive vapers’.
2.4.2 Smoking and vaping status at follow up
On the follow-up surveys, women were asked ‘How often do you use an e-cigarette or
vaping device now?’ and could select the following options: 1) Not used at all; 2) only
used once or twice; 3) used occasionally, but less than weekly; 4) used less than daily,
but at least once a week; 5) used every day.
Smoking status was determined on responses to the following statement: ‘what best
describes your smoking right now?’. Participants could select the following: 1) I don’t
smoke at all; 2) I smoke occasionally, but not every day; 3) I smoke every day, but
have cut down during my pregnancy; 4) I smoke every day, about the same as before
my pregnancy; 5) I smoke every day, and tend to smoke more than before my
pregnancy.
Women who reported quitting smoking since completing the previous survey were
defined as ‘ex-smokers’. Women were defined as ‘vapers’ if they reported they were
currently vaping either daily, using less than daily but at least once a week, using
occasionally but less than weekly, or vaping once or twice. If women reported that they
smoked either daily or occasionally and did not vape (in any capacity), then they were
defined as a ‘smoker’. Smokers who reported that they also vaped (in any capacity)
were defined as ‘dual users’. Women who reported that they did not smoke but vaped
(in any capacity) were defined as ‘exclusive vapers’.
Where follow-up surveys were missing responses to the vaping question used to define
current vaping status ‘How often do you use an e-cigarette or vaping device now?’, two
researchers independently reviewed the participant’s other responses to questions
surrounding vaping habits (follow up survey questions; A9-A17) in order to determine
vaping status.
2.5 Statistical analysis
To observe the pattern of vaping throughout pregnancy, we aimed to recruit at least 600
women into the cohort (K. Bowker et al., 2020). Analysis was conducted using Stata-SE
version 15 (StataCorp LLC, College Station, TX, USA).
We described the characteristics and smoking/vaping behaviour of the women who
completed a survey in early pregnancy, those who entered the cohort study and those
who completed all three surveys. Using chi-squared tests for categorical variables and t-
tests for continuous variables, we looked to see if there were differences between
women who only completed an early pregnancy survey and women who completed a
survey at each of the three time points. P values of <0.05 were deemed significant.
We then described cross sectional prevalence of vaping and smoking in early and late
pregnancy and the postpartum. For women who were classified as vapers at any of the
time points, we described the frequency of vaping and main reason for vaping at each
time point. We presented prevalence of vaping at each time point after excluding vapers
who report vaping only once or twice, to highlight the prevalence of women who
regularly vape during pregnancy. We also described the frequency of vaping specifically
in vapers who completed all three surveys.
We described the temporal changes in vaping status within women who completed all
three surveys to explore the patterns in individuals’ smoking and vaping habits during
pregnancy and postpartum. To investigate the impact of missing outcome data for
smoking and vaping status in late pregnancy or the postpartum we used multiple
imputation, using Stata’s mi command, based on the characteristics that were associated
with non-completion of all surveys. We included the outcome variable in the model.
Since some of the smoking/vaping categories had zero or very few observations, and in
multiple imputation proportions could be calculated for some but not all imputed
datasets due to zero observations, these rare categories were excluded from our tree
diagram.
3 Results
3.1 Summary of the survey responses
Figure 1 summarises the survey response rates. Of 1024 eligible women, 84.6%
(n=867) completed a survey in early pregnancy (baseline) and of these 86.5%
(n=750/867) joined the cohort. Surveys were returned by 52.3% (n=392/750) of the
cohort in late pregnancy (34-38 weeks gestation) and 56.0% (n=415/750) in
postpartum (3 months after having a baby). A total of 42.1% (n=316/750) of women
completed all three surveys and had complete data on their smoking and vaping status.
The characteristics of the women who completed the early pregnancy survey have been
described elsewhere (K. Bowker et al., 2020). Supplementary Table 1 shows that
compared to those who only completed the early pregnancy survey, women who
completed all three surveys were significantly more likely to be ex-smokers in early
pregnancy (p=0.003), to hold higher educational qualification (p<0.001), to have left
education at a higher age (p<0.001), to have a planned pregnancy (p<0.001) and to
report they were seriously planning on quitting smoking (p=0.012). Women from the
North and Midlands areas of England were more likely to have completed all three
surveys compared with other regions (p=0.008).
3.2 Cross sectional prevalence and frequency of vaping in early and late
pregnancy and postpartum
Table 1 shows that in early pregnancy 15.9% (n=119/750) of pregnant smokers or
recent ex-smokers reported vaping; 12.4% (n=93/750) were dual users and 3.5%
(n=26/750) were exclusive vapers. Reported vaping prevalence in late pregnancy was
17.8% (n=68/383) (of which 12.5% (n=48/383) were dual users and 5.2% (n=20/383)
exclusive vapers. In the postpartum, prevalence was 23.1% (n=95/411) of which 14.6%
(n=60/411) were dual users and 8.5% (n=35/411) were exclusive vapers. When vapers
who reported only vaping once or twice were excluded from each time point (data not
shown in table) the vaping prevalence in early pregnancy was 12.2% (n=92/750),
13.6% (n=52/383) in late pregnancy and 18.7% (n=77/411) in the postpartum.
In early pregnancy, 65.4% (n=17/26) of exclusive vapers reported vaping daily. A total
of 31.2% (n=29/93) of dual users reported vaping daily and 25.8% (n=24/93) vaped
less than daily but at least once a week. In late pregnancy (75.0%, n=15/20) and the
postpartum (77.1%, n=27/35) a greater proportion of exclusive vapers reported vaping
daily compared with early pregnancy. Among dual users a decreased proportion reported
daily vaping in late pregnancy (25.0%, n=12/48) and postpartum (23.3%, n=14/60)
compared with early pregnancy.
When observing only women who reported vaping at all three time points, in early
pregnancy most exclusive vapers reported vaping every day (66.7%, n=4/6). By late
pregnancy and the postpartum all (100%) exclusive vapers reported daily use. Dual
users varied in their daily reported vaping during pregnancy, but by the postpartum only
one dual user reported vaping daily (6.3%, n=1/16).
3.3 Longitudinal patterns of vaping during pregnancy and the postpartum
Figure 2 shows the patterns of vaping and smoking behaviour within the 316 women
who completed all three surveys and provided information on their smoking and vaping
status. Figure S1 shows the patterns of vaping and smoking at the three time points with
missing data at follow-up imputed using multiple imputation; the patterns were similar
to the non-adjusted figures.
3.3.1 Patterns of women that vape in early pregnancy
In total 2.6% (n=8/316) of women who completed all three surveys were classified as
exclusive vapers in early pregnancy; most remained exclusive vapers in late pregnancy
(87.5%, n=7/8) and the postpartum (75%, n=6/8). Exclusive vapers in early pregnancy
who were no longer exclusive vapers at later time points all became dual users.
In total 11.5% (n=35/316) of women were classified as dual users in early pregnancy;
over half remained dual users (60.0%, n=21/35) in late pregnancy, of which 76.2%
(n=16/21) were dual users in the postpartum. Some temporal changes are evident in
these dual users. For example, by the postpartum around a third (31.4%, n=11/35) of
dual users in early pregnancy were exclusive smokers. Around a quarter (n=25.7%,
n=9/35) of dual users in early pregnancy, were exclusive smokers by late pregnancy,
over half of whom remained exclusive smokers in the postpartum (66.7%, n=6/9).
Nearly a quarter (23.8%, n=5/21) of women who dual used throughout pregnancy
became exclusive smokers in the postpartum. A minority of early pregnancy dual users
(11.4%, n=4/35), became exclusive vapers by late pregnancy and remained exclusive
vapers in the postpartum. Only one dual user (2.9%, n=1/35) in early pregnancy
become an ex-smoker in late pregnancy and remained so in the postpartum.
3.3.2 Patterns of women that do not vape in early pregnancy
There were 142 women classified as smokers in early pregnancy and 68.3%
(n=97/140), remain smokers throughout. A minority of exclusive smokers in early
pregnancy were vaping in late pregnancy, either as dual users (9.9%, n=14/142), or
exclusive vapers (1.4%, n=2/142). Those who became dual users in late pregnancy
often returned to exclusive smoking in the postpartum (78.6%, n=11/14). A minority of
women who were exclusive smokers throughout pregnancy became dual users in the
postpartum (10.8%, n=12/112). Around 10% of women who were classified as ex-
smokers during early and late pregnancy started vaping postpartum; 4.6% (n=5/108)
were duals users and 4.6% (n=5/108) were exclusive vapers. A third (33.3%,
n=36/108) of ex-smokers were smoking in the postpartum.
3.4 Main reasons for vaping in early and late pregnancy and postpartum
The most frequently reported main reason to vape among exclusive vapers at each time
point was to quit smoking: in early pregnancy 65.4% (n=17/26), late pregnancy 55.0%
(n=11/20) and postpartum 57.1% (n=20/35). A minority of exclusive vapers in early
pregnancy reported that their main reason to vape was to avoid returning to smoking
(11.5%, n=3/26); this became a more frequent response in late pregnancy (25.0%,
n=5/20) and the postpartum (28.6%, n=10/35). The most frequently reported main
reason to vape among dual users was to quit smoking: early pregnancy 50.5%
(n=47/93), late pregnancy 37.5% (n=18/48) and postpartum 38.3% (n=23/60). The
second most frequently reported main reason among dual users was to cut down their
smoking: early pregnancy 30.1% (n=28/93), late pregnancy 31.3% (n=15/48) and
postpartum 28.3% (n=17/60).
4. Discussion
This is the first study to prospectively collect longitudinal data to describe pregnant
women’s vaping throughout pregnancy and the postpartum. Our findings show that
nearly 16% of pregnant smokers or ex-smokers are vaping in early pregnancy, 18% in
late pregnancy and 23% in the postpartum. Most vapers during pregnancy and the
postpartum report being dual users. We have also been able to report temporal changes
in vaping. Vaping status among exclusive vapers in early pregnancy remained stable
throughout pregnancy and the postpartum. Dual users appear less stable with around a
quarter of dual users in early pregnancy becoming exclusive smokers by late pregnancy
and a third exclusively smoking by the postpartum. A minority of women who were ex-
smokers or smokers throughout pregnancy became vapers in the postpartum.
A limitation of this study is that we relied on self-reported data. Previous studies have
shown stigma associated with both smoking and vaping during pregnancy (Katharine
Bowker et al., 2018; Laura Schilling et al., 2019) and this could potentially lead to
underreporting. However, there is some evidence that using self-reported smoking data
during pregnancy is valid (Pickett, Rathouz, Kasza, Wakschlag, & Wright, 2005) and as
there was no intervention, there was no expectation that women should stop vaping or
smoking. The surveys were completed discreetly during antenatal appointments in early
pregnancy (K. Bowker et al., 2020) and at the woman’s own discretion at follow up,
enabling women to give honest responses. The participants were predominantly white
British, similar to other UK cohorts of pregnant smokers (Orton et al., 2014), but we
recognise that our findings may not be generalisable to other ethnicities. Our follow up
rates were relatively low at 52.3% in late pregnancy and 55.3% postpartum, and only
42.1% completed all three surveys, although our multiple imputation analysis that
accounted for nonresponse bias showed similar smoking and vaping patterns to the main
analysis.
We have data on longitudinal patterns for a relatively small number of exclusive and dual
use vapers; these low numbers are possibly a reflection of low and variable levels of
vaping in pregnant populations (Whittington et al., 2018). Following a larger number of
vapers over time would likely ensure a more representative understanding of vaping
patterns. We defined vapers as anyone who reported vaping at any of the time points,
including those who reported vaping only once or twice; we did not want to exclude
infrequent vapers as we wanted to capture those experimenting with e-cigarettes.
However, the prevalence of vaping after we excluded infrequent vapers showed that
most vapers in our study used an e-cigarette more than once or twice. E-cigarette use
may change over time and could explain the increase in proportions of those vaping in
late pregnancy and the postpartum. However, when interpreting the temporal changes
of vaping, consideration should be given to the highlighted differences in characteristics,
such as education, between those that completed all three surveys and those that only
completed the early pregnancy survey.
Exclusive vapers in early pregnancy appear less likely to return to smoking in the
postpartum when compared with ex-smokers. Although we recognise the numbers of
exclusive vapers were low, this pattern is similar to studies outside of pregnancy, which
have shown rates of relapse to smoking in exclusive vapers is low over time (Farsalinos,
Romagna, Tsiapras, Kyrzopoulos, & Voudris, 2014; Pasquereau, Guignard, Andler, &
Nguyen-Thanh, 2017). Exclusive vapers appear committed to vaping; the majority
reported daily vaping throughout pregnancy and the postpartum. Little is known about
why some pregnant women can quit smoking while vaping while others struggle; finding
out more about the devices vapers use, the strengths of nicotine and adherence to e-
cigarettes could aid our understanding.
Dual users commonly returned to smoking; nearly a quarter of women who reported
being a dual user in early pregnancy were smoking exclusively by late pregnancy and
around a third of pregnant dual users in early pregnancy were smoking exclusively in the
postpartum. Dual users were less likely to report daily vaping compared to exclusive
users, so it could be that their vaping habits were insufficient to assist with smoking
cessation, or they were vaping as an alternative to smoking in some situations.
Nevertheless, like previous studies we found dual users often reported that their primary
reason for vaping was to quit smoking (Chiang et al., 2019; Fallin, Miller, Assef, &
Ashford, 2016; Wagner, Camerota, & Propper, 2017). One survey, which explored
vaping use before and during pregnancy, found only one pregnant woman switched from
dual use before pregnancy to vaping exclusively during pregnancy (L. Schilling, Spallek,
Maul, Tallarek, & Schneider, 2020). It is vital that more support is given to pregnant
dual users to help them use e-cigarettes exclusively and thereby achieve their goal of
smoking cessation. Although e-cigarettes are not risk free (American Lung Association,
2020; Britton, Arnott, McNeill, & Hopkinson, 2016; Froggatt et al., 2020), evidence
outside of pregnancy observes health benefits among vapers who stop smoking
combustible cigarettes completely (McDonnell et al., 2020; Shahab et al., 2017).
We found that nearly 11% of women who had smoked exclusively throughout pregnancy
became dual users in the postpartum, and a similar proportion of women who were ex-
smokers throughout pregnancy took up vaping (either exclusive or dual) in the
postpartum. This could reflect women choosing to experiment with e-cigarettes as a
novel product but may also be indicative of women trying to protect their new-born from
second-hand smoke exposure by using e-cigarettes instead of continuing or returning to
smoking in the postpartum period. Currently clinicians support pregnant smokers to stop
smoking; they may also need to support dual users to stop smoking and avoid returning
to smoking, and these women may have differing needs to exclusive smokers.
5. Conclusion
Between 16% and 23% of pregnant smokers and ex-smokers reported vaping at some
point during pregnancy and the postpartum period; the majority dual use but vape with
the intention to quit smoking. Temporal patterns show that the vaping habits of
exclusive vapers remains stable throughout pregnancy and the postpartum. However,
the vaping habits of dual users varies with a third becoming exclusive smokers by the
postpartum period. Exclusive vapers appear more committed to vaping and vape daily,
whereas dual users are less frequent users.
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a All participants who delivered before 34 weeks gestation were sent a follow-up 2 questionnaire.
b 11 participants were excluded from the follow-up 1 questionnaire, as they were not eligible (were not
between 34-38 weeks gestation when the follow-up was completed); they were sent follow-up 2
questionnaires.
c 97 participants who did not complete follow-up 1 questionnaire returned a follow-up 2 questionnaire.
d 9 participants were excluded who completed all 3 questionnaires but weren’t eligible to complete follow-up 1
questionnaire (were not between 34-38 weeks when the follow-up 1 was completed) and a further 4 were
excluded as they had missing information on their EC status at follow-up one or follow-up 2.
750 included in longitudinal study
4193 potential participants approached in antenatal clinic
1024 eligible women invited to participate
867 completed baseline survey
Total withdrawn from follow-up 1
questionnaire N = 62
Miscarriage/stillbirth (<34weeks) N = 8
Termination N = 2
Withdrew consent N = 11
Lost to follow-up N = 8
Advised not to contact by site N=2
Delivered <34 weeks N =20a
Completed follow -up 1 but not eligible
N=11 b
Follow-up 1 (late pregnancy) sent out N = 688
Returned N = 392
52.3 % of total cohort
57.0 % of questionnaires sent out
Total withdrawn from follow-up 2
questionnaire N= 42
Stillbirth/infant death (found out after
follow-up 1) N = 1
Infant unwell N = 1
Withdrew consent N=8
Infant under safeguarding team N = 9
Lost to follow-up N = 21
Advised not to contact by site N=2
Follow-up 2 (postpartum) sent out N = 677
Returned N = 415 c
55.3 % of total cohort
61.3 % of questionnaires sent out
Completed all 3 questionnaires N = 329 (43.9 %)
Usable data for all 3 questionnaires:
N=316 (42.1 %) d
117 did not join cohort (64 not interested/
53 unknown)
157 declined or did not complete
baseline survey
< 16 years of age N=5
>24 weeks gestation N=755
< 8 weeks gestation N=17
Completed survey before N= 20
Missing information on both smoking
and EC use N=20
Missing EC information N=12
Missing smoking information N=4
Never smoked/stopped>3months ago and
non-EC user N= 2336
Figure 1: Recruitment and flow of participants through the study
Table 1: Smoking and vaping status, frequency, and main reason for vaping in









Total who completed the survey 750 383* 411*
Smoker 384 (51.2) 168 (43.9) 218 (53.0)
Ex-smoker 247 (32.93) 147 (38.4) 98 (23.8)
Vaper (dual and exclusive) 119 (15.9) 68 (17.8) 95 (23.1)
Frequency of vaping: Dual user
Total n=93 (12.4) n=48 (12.5) n=60 (14.6)
Used every day 29 (31.2) 12 (25.0) 14 (23.3)
Used less than daily but at least once a
week
24 (25.8) 15 (31.3) 15 (25.0)
Used occasionally but less than weekly 14 (15.1) 11 (22.9) 17 (28.3)
Only used once or twice 5 (5.4) 10 (20.8) 14 (23.3)
Not used at all 11 (11.8)^ 0(0) 0(0)
Missing 10 (10.8) 0(0) 0(0)
Main reason for vaping: Dual user
To quit smoking 47 (50.5) 18 (37.5) 23 (38.3)
To cut down smoking 28 (30.1) 15 (31.3) 17 (28.3)
To avoid returning to smoking 0 (0) 0(0) 5 (8.3)
Instead of smoking around my baby n/a n/a 6 (10.0)
Other ** 4 (4.3) 3 (6.3) 2 (3.3)
Missing 12 (12.9) 12 (25.0) 7 (11.7)
Frequency of vaping: Exclusive vaper
Total n=26 (3.5) n=20 (5.2) n=35 (8.5)
Used every day 17 (65.4) 15 (75.0) 27 (77.1)
Used less than daily but at least once a
week
3 (11.5) 2 (10.0) 1 (2.9)
Used occasionally but less than weekly 5 (19.2) 0(0) 3 (8.6)
Only used once or twice 0(0) 3 (15.0) 4 (11.4)
Not used at all 1 (3.9)^ 0(0) 0(0)
Main reason for vaping: Exclusive
vaper
To quit smoking 17 (65.4) 11 (55.0) 20 (57.1)
To cut down smoking 0(0) 0(0) 0(0)
To avoid returning to smoking 3 (11.5) 5 (25.0) 10 (28.6)
Instead of smoking around my baby n/a n/a 0 (0)
Other ** 1 (3.9) 2 (10.0) 3 (8.7)
Missing 5 (19.2) 2 (10.0) 2 (5.7)
*5 women did not provide information on smoking/vaping in late pregnancy and 4 women did not provide
information on smoking/vaping in the postpartum
**‘Other’ includes: Curiosity, enjoyment, to use when I am not allowed to smoke, don’t know and other
(unknown).
^ The early pregnancy survey responses contained women who stated that they vaped, but then reported
having ‘not used at all’ in their response to a question about frequency of vaping. Figure 2: Patterns
of vaping and smoking throughout pregnancy

Supplementary Table 1: Characteristics for all women who completed



















Smoker 434 (50.1%) 384 (51.2%) 142 (44.9%)
0.003Ex-smoker 293 (33.8%) 247 (32.9%) 131 (41.5%)
Exclusive vaper 33 (3.8%) 26 (3.5%) 8 (2.5%)
Dual user 107 (12.3%) 93 (12.4%) 35 (11.1%)
Age
Median[1st Q, 3rd Q] 26 (22-31) 26 (22-31) 26 (23-31) 0.067
Missing ± 3 2 1
Region
North 290 (33.5%) 264 (35.2%) 115 (36.4%) 0.008
South 111 (12.8%) 87 (11.6%) 41 (13.0%)
Midlands 283 (32.6%) 267 (35.6%) 109 (34.5%)
London 100 (11.5%) 87 (11.6%) 36 (11.4%)









348 (40.1) 304 (40.5%) 163 (50.9%)
Missing ± 17 (2.0%) 7 (0.9%) 3 (1.0%)
16 and under 415 (47.9%) 368 (49.1%) 131 (41.5%) <0.001
Age left education
17 and above 408 (47.1%) 352 (46.9%) 175 (55.4%)
Still in education 25 (2.9%) 21 (2.8%) 9 (2.9%)
Missing ± 19 (2.2%) 9 (1.2%) 1 (0.3%)
Ethnicity
White British 759 (87.5%) 662 (88.3%) 274 (86.7%) 0.286
Other 63 (11.1%) 84 (11.2%) 40 (12.7%)
Missing ± 12 (1.4%) 4 (0.5%) 2 (0.6%)
Gestation at
recruitment (weeks)
First trimester 399 (46.0%) 337 (44.9) 139 (44.0) 0.270
Second trimester 460 (53.1) 413 (55.1) 177 (56.0)








561 (64.7%) 490 (65.3%) 205 (64.9%)
Missing ± 18 (2.1%) 12 (1.6%) 4 (1.3%)
If yes – smoked in
previous pregnancy
N=561 N=490 N=205
Yes 345 (61.5%) 307 (62.7%) 122 (60.0%) 0.435
No 197 (35.1%) 165 (33.7%) 75 (36.6%)
Don’t remember 12 (2.1%) 12 (2.5%) 6 (2.9%)
Missing ± 7 (1.3%) 6 (0%) 2 (1.0%)
Planned pregnancy
Yes 292 (33.7%) 252 (33.6%) 130 (41.1%) <0.001
No 548 (63.2%) 480 (64.0%) 177 (56.0%)
Missing ± 27 (3.1%) 18 (2.4%) 9 (2.9%)
Tried to stop smoking
since becoming
pregnant
Yes 639 (73.7%) 554 (73.9%) 228 (72.2%) 0.179
No 142 (16.4%) 127 (16.9%) 53 (16.8%)
Stop smoking
before pregnancy
61 (7.0%) 53 (7.1%) 27 (8.5%)
Missing ± 25 (2.7%) 16 (2.1%) 8 (2.5%)
Current smokers only 541 477 177
Last smoked In last 24 hours 470 (86.9%) 419 (87.8%) 154 (87.0%) 0.487
Over 24 hours 59 (10.9%) 50 (10.5%) 22 (12.4%)









158 (29.2%) 143 (30.0%) 57 (32.2%)
Missing ± 38 (7.0%) 28 (5.9%) 7 (4.0%)
Cigarettes smoked per
day
0-10 387 (71.5%) 341 (71.5%) 123 (69.5%) 0.476
≥ 11 128 23.7%) 116 (24.3%) 48 (27.1%)
Missing ± 26 (4.8%) 20 (4.2%) 6 (3.4%)
Seriously planning to
quit smoking
Yes 362 (66.9%) 326 (68.3%) 131 (74.0%) 0.012
No 128 (23.7%) 112 (23.5%) 36 (20.3%)
Missing ± 51 (9.4%) 39 (8.2%) 10 (5.7%)
± missing excluded from chi squared tests
Supplementary Figure 1: smoking and vaping patterns using multiple
imputation.
